There is no commercial support for this activity.

About the speaker

Bradley Stein (he/him) is director of the NIH funded RAND Opioid Policy Center and a senior physician policy researcher at the RAND Corporation. A health services and policy researcher and practicing child and adolescent psychiatrist, Stein's research focuses on better understanding and improving care for individuals with mental health and substance use disorders in community settings. Dr. Stein has worked extensively in recent years examining the effects of state policies and community characteristics on outcomes related to the opioid crisis, including treatment, prevention, and harm reduction. He has also worked in the area of school mental health, developing, evaluating, implementing, and disseminating a school-based intervention for students exposed to trauma and violence as well as a school-based suicide intervention program’s implementation. In addition, he has examined the mental health and substance abuse care of a broad range of Medicaid enrollees, including individuals with depression, children with ADHD, children with autism, children receiving psychotropic medications, and individuals with opioid use disorder and other substance use disorders. Dr. Stein previously served as the senior director of Research, Evaluation, and Outcomes at Community Care Behavioral Health, a large non-profit managed behavioral health organization. He is a previous standing member of the NIMH Services Study Section and served on the editorial boards of the Journal of the American Academy of Child and Adolescent Psychiatry and Psychiatric Services.

Disclosure Statements

Sheppard Pratt holds the standard that its continuing medical education programs should be free of commercial bias and conflict of interest. In accord with Sheppard Pratt's Disclosure Policy, as well as standards of the Accreditation Council for Continuing Medical Education (ACCME) and the American Medical Association (AMA), all planners, reviewers, speakers and persons in control of content have been asked to disclose any relationship he/she has with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months. All planners, reviewers and speakers have also been asked to disclose any payments accepted for this lecture from any entity besides Sheppard Pratt, and if there will be discussion of any products, services or off-label uses of product(s) during this presentation.

Bradley D. Stein, PhD, MD, MPH, reports as having no financial interest, arrangement or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 12 months, This presentation was initially planned and recorded prior to January 1, 2023; therefore, the financial disclosure statement from the speaker reflects only the preceding 12 months, as was the standard at the time. This enduring activity was last reviewed for content validity on December 4, 2023. All conflicts have been mitigated through review.

Event Planners/Reviewers Disclosures: The following event planners and/or reviewers are reported as having no financial interest, arrangement or affiliation with any entity producing, marketing, selling, re-selling, or distributing health care goods or services consumed by, or used on, patients, during the past 24 months: Todd Peters, MD, Deepak Prabhakar, MD, Elizabeth Ryznar, MD, MSc, Louis Marino, MD, Ehsan Syed, MD, Devi Bhuyan, PsyD, Faith Dickerson, PhD, Carrie Etheridge, LCSW-C, Tom Flis, LCPC, Stacey Garnett, RN, MSN, Stephanie M. Robinson, MSN, RN, PMH-BC, NPD-BC, NE-BC , Heather Billings, RN, Lisa Illum, MLIS, MEd, and Jennifer Tornabene.